Aisling Capital Management LP Verona Pharma PLC Transaction History
Aisling Capital Management LP
- $243 Million
- Q3 2024
A detailed history of Aisling Capital Management LP transactions in Verona Pharma PLC stock. As of the latest transaction made, Aisling Capital Management LP holds 1,115,352 shares of VRNA stock, worth $66.4 Million. This represents 13.2% of its overall portfolio holdings.
Number of Shares
1,115,352
Previous 1,115,352
-0.0%
Holding current value
$66.4 Million
Previous $16.1 Million
98.97%
% of portfolio
13.2%
Previous 7.06%
Shares
3 transactions
Others Institutions Holding VRNA
# of Institutions
175Shares Held
68.9MCall Options Held
704KPut Options Held
685K-
Perceptive Advisors LLC New York, NY6.32MShares$376 Million4.75% of portfolio
-
Nea Management Company, LLC Timonium, MD5.58MShares$332 Million12.27% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.01MShares$298 Million2.01% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx4.22MShares$251 Million2.52% of portfolio
-
Vivo Capital, LLC Palo Alto, CA3.55MShares$211 Million14.95% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $3.63B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...